Echo Revolve Microscope

The Food and Drug Administration is forecasting the acquisition of an Echo Revolve R4 microscope to be housed in the Kemaladewi Laboratory within the Gene Therapy Immunology Branch. This instrument is designed to provide both upright and inverted imaging, supporting brightfield and multi-channel fluorescence imaging for the characterization and evaluation of gene therapy products. By combining these capabilities into a single instrument, the agency aims to reduce the need for multiple microscopes. This procurement will replace an existing brightfield-only microscope, significantly expanding the laboratory's imaging capabilities to better support ongoing research and regulatory science activities. The opportunity is categorized under NAICS code 333314, with program inquiries directed to the CBER Acquisition Liaison.